Substrate and inhibitor selectivity, and biological activity of an epoxide hydrolase from Trichoderma reesei

被引:0
作者
Gabriel S. de Oliveira
Patricia P. Adriani
Hao Wu
Christophe Morisseau
Bruce D. Hammock
Felipe S. Chambergo
机构
[1] Universidade de São Paulo,Escola de Artes, Ciências e Humanidades
[2] University of California,Department of Entomology and Nematology, and UC Davis Comprehensive Cancer Center
来源
Molecular Biology Reports | 2019年 / 46卷
关键词
Epoxide hydrolase; EH inhibitors; Epoxy fatty acids; Growth inhibitory activity;
D O I
暂无
中图分类号
学科分类号
摘要
Epoxide hydrolases (EHs) are present in all living organisms and catalyze the hydrolysis of epoxides to the corresponding vicinal diols. EH are involved in the metabolism of endogenous and exogenous epoxides, and thus have application in pharmacology and biotechnology. In this work, we describe the substrates and inhibitors selectivity of an epoxide hydrolase recently cloned from the filamentous fungus Trichoderma reesei QM9414 (TrEH). We also studied the TrEH urea-based inhibitors effects in the fungal growth. TrEH showed high activity on radioative and fluorescent surrogate and natural substrates, especially epoxides from docosahexaenoic acid. Using a fluorescent surrogate substrate, potent inhibitors of TrEH were identified. Interestingly, one of the best compounds inhibit up to 60% of T. reesei growth, indicating an endogenous role for TrEH. These data make TrEH very attractive for future studies about fungal metabolism of fatty acids and possible development of novel drugs for human diseases.
引用
收藏
页码:371 / 379
页数:8
相关论文
共 289 条
[1]  
Morisseau C(2013)Role of epoxide hydrolases in lipid metabolism Biochimie 95 91-95
[2]  
Morisseau C(2005)Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles Annu Rev Pharmacol Toxicol 45 311-333
[3]  
Hammock BD(1995)Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1 Proc Natl Acad Sci USA 92 2384-2387
[4]  
McGlynn KA(2013)mEH Tyr113His polymorphism and the risk of ovarian cancer development J Ovarian Res 6 40-157
[5]  
Rosvold EA(2005)Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma Cancer Epidemiol Biomark Prev 14 152-883
[6]  
Lustbader ED(2011)Genetic polymorphisms of xenobiotic-metabolizing enzymes influence the risk of pulmonary emphysema Pharmacogenet Genom 21 876-1649
[7]  
Hu Y(2006)Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study Hum Mol Genet 15 1640-998
[8]  
Clapper ML(2000)Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids Circ Res 87 992-2227
[9]  
Zhou T(2002)Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation Proc Natl Acad Sci USA 99 2222-9777
[10]  
Wild CP(2005)Soluble epoxide hydrolase is a therapeutic target for acute inflammation Proc Natl Acad Sci USA 102 9772-11395